コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dysfunction by reducing the unstressed left ventricular end-diastolic volume.
2 6+/-58 mm(3) at follow-up, P=0.006) of right ventricular end-diastolic volume.
3 ricular ejection fraction, and indexed right ventricular end-diastolic volume.
4 emoglobin mass, total blood volume, and left-ventricular end-diastolic volume.
5 including after adjustment for baseline left ventricular end-diastolic volume.
6 ed as an increase of 15% or more in the left ventricular end-diastolic volume.
7 ter mean LVMT was associated with lower left ventricular end-diastolic volume (0.01 mm/mL; P<0.01), a
8 sponse (defined as percent reduction in left ventricular end-diastolic volume 1 year after CRT-D impl
9 s had mildly dilated right ventricles (right ventricular end-diastolic volume=101+/-26 mL/m(2)) with
10 stroke volume (SV) without a change in left ventricular end diastolic volume (102+/-16% change from
11 rsus 1.4 respectively; P=0.01) as were right ventricular end-diastolic volumes (113.7 30.9 versus 90
13 rdial function on cardiac MRI including left ventricular end diastolic volume (-13 [28] vs 10 [26] mL
14 133 beats per minute +/- 19, P < .001), left ventricular end-diastolic volume (140 mL +/- 32 vs 148 m
16 0.4 +/- 2 to 7.7 +/- 4 mL; p < .05) and left ventricular end-diastolic volume (18.5 +/- 3 to 14.2 +/-
17 with placebo, a significant decrease in left ventricular end-diastolic volume (-18 mL; P=0.009) and e
18 shown by increased E-wave velocity and left ventricular end-diastolic volume, 2) exhibit a higher pl
19 ventricular remodeling (>20% change in left ventricular end-diastolic volume; 21.91 [2.75-174.29]; P
20 tolic pressure by 40% to 60% (p < .05), left ventricular end-diastolic volume 25 +/- 8%, and stroke v
22 a was linearly related to reductions in left ventricular end-diastolic volume (-4.1 ml; 95% confidenc
23 ificantly (P<0.05) greater reduction in left ventricular end-diastolic volume (-49+/-16% versus -35+/
25 84.0% versus 87.0%) and improvement in left ventricular end-diastolic volume (-8.0 mL versus -12.7 m
27 (54 +/- 10 to 87 +/-6 mL; p < .05) and right ventricular end-diastolic volume (90 +/-11 to 128 +/- 18
29 the parasternal short axis view, to the left ventricular end-diastolic volume acquired using the bipl
30 with change in RV ejection fraction and left ventricular end-diastolic volume, although correlation c
33 odilation reflected by a 10% decline in left ventricular end-diastolic volume and a 30% fall in atria
35 ndary end points, including structural (left ventricular end-diastolic volume and left ventricular ej
36 on compared with placebo did not change left ventricular end-diastolic volume and left ventricular ma
38 d 10 weeks after infarction showed that left ventricular end-diastolic volume and mass increased and
39 was associated with modest reduction in left ventricular end-diastolic volume and preserved global lo
40 and 24+/-5 g/m(2); P<0.001) and indexed left ventricular end-diastolic volume and right ventricular e
41 -of-life score, 6-minute walk distance, left ventricular end-diastolic volume, and left ventricular e
42 s showed a borderline (16%) increase in left ventricular end-diastolic volume (angiography), whereas
43 The limits of agreement between the left ventricular end-diastolic volume as estimated by bioimpe
44 me unloading results in a reduction in right ventricular end-diastolic volume, as expected, but left
46 ction fraction (beta=-0.02/%; P=0.015), left ventricular end-diastolic volume (beta=0.01/mL; P<0.0001
47 there was a 48% (P < .001) reduction in left ventricular end diastolic volume, beyond that achievable
48 right ventricular end-diastolic volume (left ventricular end-diastolic volume/body surface area, 104+
49 104+/-13 and 69+/-18 mL/m(2); P<0.001; right ventricular end-diastolic volume/body surface area, 110+
50 r end-diastolic pressure by 30% to 40%, left ventricular end-diastolic volumes by 33 +/- 9%, and tran
51 Pulmonary capillary wedge pressures and left ventricular end-diastolic volumes by use of echocardiogr
52 t ventricular remodelling, with reduced left ventricular end-diastolic volume (by 8%, P < 0.001) and
53 The relation between stroke volume and left ventricular end-diastolic volume, by the Frank-Starting
54 timates of ventricular filling pressures and ventricular end-diastolic volumes/cardiac performance va
55 interval, -4.02 to -0.23; P=0.028) and left ventricular end-diastolic volume (coefficient, 7.85; 95%
56 ociated with a significant reduction in left ventricular end-diastolic volume compared with the nonca
57 end-diastolic pressure (LVEDP), but not left ventricular end-diastolic volume, consistent with increa
60 ipping led to a significant increase in left ventricular end-diastolic volume, demonstrating increase
62 sociation with an expected decrease in right ventricular end-diastolic volume during lower-body sucti
64 sonance imaging demonstrated increasing left ventricular end-diastolic volumes, end-systolic volumes,
65 on >=10% and improvement in the indexed left ventricular end diastolic volume >=10% at 12 months.
66 rior hospitalization for heart failure, left ventricular end-diastolic volume >/=125 mL/m(2), and lef
67 emodeling was defined as an increase in left ventricular end-diastolic volume >/=20% at 6 months.
70 r pressure increase and dilatation, but left ventricular end-diastolic volume improved because of red
72 ts, there was a paradoxical increase in left ventricular end-diastolic volume in association with an
73 mm Hg lower-body suction, on right and left ventricular end-diastolic volumes in 21 patients with ch
74 to 43+/-14 mL/m(2), P<0.0001), whereas left ventricular end diastolic volume increased (66+/-12 to 7
76 After 17 cycles of trastuzumab, indexed left ventricular end diastolic volume increased in patients t
78 Maximal left atrial volume index and left ventricular end diastolic volume index, ambulatory pulse
79 ing without surgery at 5 years, 90% for left ventricular end-diastolic volume index <100 mL/m(2) vers
80 us-ICD group had greater improvement in left ventricular end-diastolic volume index (-26.2 versus -7.
81 [95% CI, -8.5 to -0.1] mL/m2; P = .04), left ventricular end-diastolic volume index (-5.5 [95% CI, -1
82 a brain natriuretic peptide (79 pg/mL), left ventricular end-diastolic volume index (110 mL/m2), and
83 cause the degree of SMR relative to the left ventricular end-diastolic volume index (LVEDVi) was subs
84 not correlate with six-month changes in left ventricular end-diastolic volume index (p = 0.26), LVESV
85 phy showed a small, stable reduction in left ventricular end-diastolic volume index (P<0.001), with a
88 3.2 +/- 2.9 years, LVEF 0.21 +/- 0.07, left ventricular end-diastolic volume index 180 +/- 64 ml/m2.
91 .001) increase in change from baseline right ventricular end-diastolic volume index and a 429 ml (P <
94 ulmonary artery occlusion pressure, and left ventricular end-diastolic volume index failed to correla
97 lic volume index threshold of 227% or a left ventricular end-diastolic volume index of 58 ml/m(2) ide
98 ry outcome was change from baseline in right ventricular end-diastolic volume index versus placebo.
99 f SCA were PET sympathetic denervation, left ventricular end-diastolic volume index, creatinine, and
100 MP-2 levels were associated with larger left ventricular end-diastolic volume index, greater left ven
101 atrial area, left atrial volume index, left ventricular end-diastolic volume index, peak E wave, and
102 tion, initial central venous pressure, right ventricular end-diastolic volume index, pulmonary artery
105 95% CI, 1.8-12.8]; P=0.002) and greater left ventricular end-diastolic volume indexed (hazard ratio,
106 remained predictive after adjusting for left ventricular end-diastolic volume indexed (hazard ratio,
107 olute ventilatory anaerobic threshold, right ventricular end-diastolic volume indexed, ventilatory an
108 t ventricular end-diastolic volume and right ventricular end-diastolic volume (left ventricular end-d
109 zone and its percentage of myocardium, left ventricular end-diastolic volume, left ventricular end-s
110 rdial scar volume by CMR is superior to left ventricular end-diastolic volume, left ventricular end-s
111 cant improvements in ejection fraction, left ventricular end-diastolic volume, left ventricular end-s
112 the following quantitative results: (a) left ventricular end-diastolic volume (LVDV) of 165 mL (LVDV/
113 the following quantitative results: (a) left ventricular end-diastolic volume (LVDV) of 165 mL (LVDV/
114 itative results were obtained with MRI: Left ventricular end-diastolic volume (LVDV) was 40 mL (LVDV
115 itative results were obtained with MRI: Left ventricular end-diastolic volume (LVDV) was 40 mL (LVDV
116 entricular ejection fraction (LVEF) and left ventricular end diastolic volume (LVEDV) on cardiac magn
118 onist tolvaptan (30 mg/day) on reducing left ventricular end-diastolic volume (LVEDV) compared with p
119 less than 40% to 50% or greater, whose left ventricular end-diastolic volume (LVEDV) had normalised,
121 ry capillary wedge pressure (PCWP), SV, left ventricular end-diastolic volume (LVEDV), and left ventr
122 ing a multivariable MR framework (e.g., left ventricular end-diastolic volume (LVEDV), Beta = 0.33, 9
124 with CRT, defined as percent change in left ventricular end-diastolic volume (LVEDV), was analyzed i
126 mL, P < 0.001; [95% CI 113 to 455]) and left ventricular end-diastolic volume (LVEDV; +10 mL, P < 0.0
127 -3.46 mL/m(2) [-5.8 to -1.2], P=0.003, right ventricular end-diastolic volume/m(2): -4.2 mL/m(2) [-6.
128 -6.8% to 2.1%]; P = .29) or changes in left ventricular end-diastolic volume (mean difference, 13.4
129 ratio, 1.16; P=0.002), exercise indexed left ventricular end-diastolic volume (odds ratio, 1.04; P=0.
131 VOT) gradient (P = 0.01), and increased left ventricular end-diastolic volume (P = 0.02) and stroke v
132 end-diastolic volume, as expected, but left ventricular end-diastolic volume paradoxically increases
133 ular end-diastolic pressure (LVEDP) and left ventricular end-diastolic volume (preload) in CHF rats,
134 n fraction (r = -0.606), higher indexed left ventricular end-diastolic volume (r = 0.572), and higher
135 thod (n=53, r=0.85, P<0.0001), and with left ventricular end-diastolic volume (r=0.81, P<0.0001).
136 -beam computed tomography for measuring left ventricular end-diastolic volume (r=0.96; standard error
137 splayed an additional decline in the RV/left ventricular end-diastolic volume ratio (P=0.05) and tren
138 ricular ejection fraction, and indexed right ventricular end-diastolic volume resulted in significant
139 ; and ejection fraction of 52% and (b) right ventricular end-diastolic volume (RVDV) of 163 mL (RVDV/
140 , and ejection fraction of 52% and (b) right ventricular end-diastolic volume (RVDV) of 163 mL (RVDV/
143 ange or change of 15 to 30 mL in 3DTTE right ventricular end-diastolic volume; sample sizes were 2x t
144 ow obstruction are inversely related to left ventricular end-diastolic volume, stroke volume, and car
145 earts increased relaxation velocity and left ventricular end diastolic volume to produce higher left
146 aval occlusion (VCO) was used to reduce left ventricular end-diastolic volume to 70 +/- 5% of baselin
147 s minor, and a decrease in the ratio of left ventricular end-diastolic volume to body weight reflecte
148 ume (angiography), whereas the ratio of left ventricular end-diastolic volume to body weight was redu
150 regurgitant fraction was 34+/-17%, and right ventricular end-diastolic volume was 114+/-39 cc/m(2).
151 genic right ventricular dysplasia, but right ventricular end-diastolic volume was decreased in RyR2(R
155 At 6 months follow-up, left atrial and left ventricular end-diastolic volumes were significantly mor
156 eat stress did not significantly change left ventricular end-diastolic volume, while ventricular end-
157 most recent echocardiogram, the median left ventricular end-diastolic volume z score was +1.7 (range
158 with published normal values, left and right ventricular end-diastolic volume z scores were mildly en
159 nsion z-score (OR=2.2, P=0.02) or lower left ventricular end-diastolic volume z-score (OR=1.9, P=0.03